As lawmakers deal with their own awkward situation related to the jacked-up costs of the EpiPen, a celebrity is taking her own stand. Sarah Jessica Parker—who Gizmodo notes has campaigned for anaphylaxis awareness for manufacturer Mylan in the name of her son, who has a severe peanut allergy—announced Thursday she's severed ties with the company because of the EpiPen's ever-increasing sticker shock, Us Weekly reports. "I'm left disappointed, saddened, and deeply concerned by Mylan's actions," she wrote in a Thursday Instagram post, calling the cost for many people "prohibitive." "I do not condone this decision and I have ended my relationship with Mylan as a direct result of it."
Parker added she hoped the company would "seriously consider the outpouring of voices" on the issue and "take swift action" to make the device more affordable. It's a public outcry Mylan has started to address by expanding its assistance programs and offering a savings card. "As a mother, I can assure you, the last thing that we would ever want is no one to have their EpiPen due to price," Mylan CEO Heather Bresch told CNBC Thursday, adding, "No one's more frustrated than me" about the broken health-care system she says is responsible for steep drug costs. This piece at Slate digs deep into that statement. (Read more Sarah Jessica Parker stories.)